Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Stopped low accrual
Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
- DRUG: cyclophosphamide
- DRUG: fludarabine phosphate
- BIOLOGICAL: NY-ESO-1 reactive TCR retroviral vector transduced autologous PBL
- BIOLOGICAL: dendritic cell vaccine therapy
- BIOLOGICAL: aldesleukin
- RADIATION: fludeoxyglucose F 18
- PROCEDURE: positron emission tomography
- OTHER: laboratory biomarker analysis
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators